Blood cancer drug safety checked in small Follow-Up study
NCT ID NCT02494258
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the long-term safety of an oral chemotherapy drug (azacitidine) in 5 adults with blood cancers who had already taken it in earlier studies. Researchers tracked side effects and survival to see if continued treatment was safe. The goal was to monitor risks, not to test if the drug works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Local Institution - 101
Gainesville, Florida, 32610-0277, United States
-
Local Institution - 102
Houston, Texas, 77030, United States
-
Local Institution - 103
Baltimore, Maryland, 21231, United States
-
Manchester Royal Infirmary
Manchester, M13 9WL, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple screening program could transform cancer aftercare
- A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
- Can a new immune drug outsmart Hard-to-Treat tumors?
- AI platform aims to unlock Real-World cancer data on a massive scale
- Can a simple text message transform cancer care?
- Can modern Radiotherapy's late effects be predicted?